Infection

, Volume 7, Issue 5, pp 220–222 | Cite as

Quantitative correlation between the dane particle-associated DNA polymerase and the hepatitis B e antigen

  • W. Siegert
  • J. Grunst
  • W. Wilmanns
  • G. G. Frösner
  • F. Deinhardt
Originalia

Summary

In order to evaluate the potential infectivity of blood of hepatitis B patients, the Dane particle associated DNA polymerase was determined, which is a reliable marker for the presence of complete viral particles. Enzyme activities were compared with hepatitis B e antigen (HBeAg) titers determined by radioimmunoassay. Detectable DNA polymerase activity was only present in HBeAg positive blood, preferentially in samples with high antigen titers (1 : 1000 and above). These samples therefore have to be considered as highly infectious. However, blood with low HBeAg levels and free of detectable polymerase activity can still be infectious, since the polymerase reaction is rather insensitive compared to the radioimmunological HBeAg determination.

Keywords

Polymerase Activity Quantitative Correlation Potential Infectivity High Antigen Antigen Titer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Quantitative Korrelation zwischen der Dane Partikel-assoziierten DNS-Polymerase und dem Hepatitis B e Antigen

Zusammenfassung

Zur Beurteilung der möglichen Infektiosität von Blut von an Hepatitis B erkrankten Patienten wurde die Dane Partikel-assoziierte DNS-Polymerase bestimmt. Diese ist ein zuverlässiger Marker für die Anwesenheit kompletter Viruspartikel. Die Enzymaktivitäten wurden mit den im Radioimmunassay bestimmten Hepatitis B e Antigen (HBeAg)-Titern verglichen. Meßbare DNS-Polymeraseaktivität war nur in HBeAg-positivem Blut vorhanden, vorzugsweise in Proben mit hohen Antigentitern (1 : 1000 und darüber). Aus diesem Grund müssen solche Proben als höchst infektiös angesehen werden. Jedoch kann Blut mit niedrigen HBeAg-Spiegeln und ohne nachweisbare DNS-Polymerase trotzdem infektiös sein, da die Polymerasereaktion relativ unempfindlich ist, verglichen mit der radioimmunologischen HBeAg-Bestimmung.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature

  1. 1.
    Deinhardt, F. Hepatitis in primates. Adv. Virus Res. 20 (1976) 113–157.Google Scholar
  2. 2.
    Nordenfelt, E., Andren-Sandberg, M. Dane particle-associated DNA polymerase and e antigen: Relation to chronic hepatitis among carriers of hepatitis B surface antigen. J. infect. Dis. 134 (1976) 85–89.Google Scholar
  3. 3.
    Hess, G., Arnold, W., Shih, W.-K., Kaplan, P. M., Purcell, R. H., Gerin, J. L., Meyer zum Bueschenfelde, K. H. Expression of hepatitis B virus-specific markers in asymptomatic hepatitis B surface antigen carriers. Infect. Immun. 17 (1977) 550–554.Google Scholar
  4. 4.
    Nordenfelt, E., Kjellén, L. Dane particles, DNA polymerase, and e antigen in two different categories of hepatitis B antigen carriers. Intervirology 5 (1975) 225–232.Google Scholar
  5. 5.
    Magnius, L. O., Espmark, J. Å. New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J. Immunol. 109 (1972) 1017–1021.Google Scholar
  6. 6.
    Shikata, T., Karasawa, T., Abe, K., Uzawa, T., Suzuki, H., Oda, T., Imai, M., Mayumi, M., Moritsugu, Y. Hepatitis B e antigen and infectivity of hepatitis B virus. J. infect. Dis. 136 (1977) 571–576.Google Scholar
  7. 7.
    Maynard, J. E., Barrett, D. H., Murphy, B. L., Bradley, D. W., Berquist, K. R., Bender, T. R. Relation of e antigen to hepatitis B virus infection in an area of hyperendemicity. J. infect. Dis. 133 (1976) 339–342.Google Scholar
  8. 8.
    Okada, K., Kamiyama, I., Inomata, M., Imai, M., Miyakawa, Y., Mayumi, M. E antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. New Engl. J. Med. 294 (1976) 746–749.Google Scholar
  9. 9.
    Alter, J. H., Seeff, L. B., Kaplan, P. M., McAuliffe, V. J., Wright, E. C., Gerin, J. L., Purcell, R. H., Holland P. V., Zimmermann, H. J. Type B hepatitis: The infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. New Engl. J. Med. 295 (1976) 909–913.Google Scholar
  10. 10.
    Frösner, G. G., Brodersen, M., Papaevangelou, G., Sugg, U., Haas, H., Mushahwar, I. K., Ling, C.-M., Overby, L. R., Deinhardt, F. Detection of HBeAg and anti-HBe in acute hepatitis B by a sensitive radioimmunoassay. J. med. Virol. 3 (1978) 67–76.Google Scholar
  11. 11.
    Takahashi, K., Yamashita, S., Imai, M., Miyakawa, Y., Mayumi, M. Failure of antibody to e antigen to precipitate Dane particles containing DNA polymerase activity and hepatitis B core antigen. J. Gen. Virol. 38 (1978) 431–436.Google Scholar
  12. 12.
    Neurath, A. R., Trepo, C., Chen, M., Prince, A. M. Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen. J. Gen. Virol. 30 (1976) 277–285.Google Scholar
  13. 13.
    Millman, I., Magnius, L. O. HBeAg and anti-HBe. In:Vyas, G. N., Cohen, S. N., Schmid, R. (ed.): Viral hepatitis. A contemporary assessment of etiology, epidemiology, pathogenesis and prevention, p. 159–216. Franklin Institute Press, Philadelphia 1978.Google Scholar
  14. 14.
    Kaplan, P. M., Greenman, R. L., Gerin, J. L., Purcell, R. H., Robinson, W. S. DNA polymerase associated with human hepatitis B antigen. J. Virol. 12 (1973) 995–1005.Google Scholar

Copyright information

© Verlagsgesellschaft Otto Spatz 1979

Authors and Affiliations

  • W. Siegert
    • 1
  • J. Grunst
    • 1
  • W. Wilmanns
    • 1
  • G. G. Frösner
    • 2
  • F. Deinhardt
    • 2
  1. 1.III. und II. Medizinische Klinik im Klinikum GroßhadernMunich 70West Germany
  2. 2.Max von Pettenkofer Institut für Hygiene und medizinische MikrobiologieMunich 2West Germany

Personalised recommendations